anecortave acetate has been researched along with Cancer of the Retina in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boutrid, H; Cebulla, CM; Feuer, WJ; Jockovich, ME; Lampidis, TJ; Murray, TG; Piña, Y | 1 |
Bajenaru, ML; Cebulla, CM; Feuer, W; Jockovich, ME; Marin Castaño, ME; Murray, TG; Piña, Y | 1 |
Escalona-Benz, E; Feuer, W; Hernandez, E; Jockovich, ME; Murray, TG | 1 |
Bajenaru, ML; Feuer, W; Fini, ME; Jockovich, ME; Murray, TG; Piña, Y; Suarez, F | 1 |
Arnold, J; Hunyor, A; Karacorlu, M; Kelly, S; Wilson, D | 1 |
Alegret, A; Cebulla, C; Feuer, W; Hayden, B; Jockovich, ME; Murray, TG; Piña, Y; Suarez, F | 1 |
6 other study(ies) available for anecortave acetate and Cancer of the Retina
Article | Year |
---|---|
Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carboplatin; Disease Models, Animal; Hypoxia; Mice; Mice, Transgenic; Microscopy, Confocal; Neovascularization, Pathologic; Nitroimidazoles; Pregnadienediols; Retinal Neoplasms; Retinoblastoma | 2009 |
Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.
Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Fluorescent Antibody Technique, Indirect; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Transgenic; Pregnadienediols; Retinal Neoplasms; Retinoblastoma; Up-Regulation | 2010 |
Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
Topics: Animals; Antineoplastic Agents; Carboplatin; Chemotherapy, Adjuvant; Disease Models, Animal; Dose-Response Relationship, Drug; Injections; Mice; Mice, Transgenic; Pregnadienediols; Retinal Neoplasms; Retinoblastoma | 2006 |
Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
Topics: Actins; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Bibenzyls; Biomarkers, Tumor; Cell Proliferation; Disease Models, Animal; Endoglin; Endothelium, Vascular; Intracellular Signaling Peptides and Proteins; Ki-67 Antigen; Mice; Mice, Transgenic; Microscopy, Fluorescence; Neovascularization, Pathologic; Pericytes; Pregnadienediols; Retinal Neoplasms; Retinoblastoma; Stilbenes | 2007 |
Diagnostic and therapeutic challenges.
Topics: Adult; Angiogenesis Inhibitors; Combined Modality Therapy; Epiretinal Membrane; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Laser Coagulation; Macular Edema; Neoplasm Recurrence, Local; Pregnadienediols; Retinal Neoplasms; Retinal Neovascularization; Vision Disorders; Visual Acuity; von Hippel-Lindau Disease | 2007 |
Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carboplatin; Caspase 3; Disease Models, Animal; Endothelium, Vascular; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Neovascularization, Pathologic; Pregnadienediols; Radiotherapy, Conformal; Retinal Neoplasms; Retinoblastoma; Stilbenes; Time Factors | 2007 |